News
Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their ...
Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...
Sanofi announced plans to invest “at least” $20 billion in the US through 2030, following similar commitments made by several ...
Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...
The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...
The latest health news highlights Sanofi's $20 billion U.S. investment through 2030, Merck's cancer drug expansion and the ...
Explore more
Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.
Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...
Sanofi India's EBITDA rose 25% to ₹171.9 crore in Q4, with margins improving to 32.1%. Shares closed 2.3% higher at ₹6,066.55 ...
Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...
(Reuters) -French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results